Prosensa
Provides RNA-based therapeutics for the treatment of genetic disorders, infections and cancers.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD1.1b (Public information from Nov 2014)
Company register number 28076693
Leiden South Holland (HQ)
Authorizing premium user...